Could interspecies differences in the protein binding of flavone acetic acid contribute to the failure to predict lack of efficacy in patients?
We investigated the differences in plasma protein binding of flavone acetic acid (FAA) in mice and men in an attempt to explain the inter-species differences in response. In vitro data indicate both qualitative and quantitative differences in FAA protein binding: approximately 80% is bound in humans, with two different types of binding site identified; in mice, 70% is bound and only one binding site could be described. Protein binding is dose-dependent in both species. Plasma samples from 20 patients receiving FAA showed that most achieved levels that would be active in mice. We conclude that these differences in protein binding are insufficient to explain totally the observed differences in response.
Cassidy
J
J
CRC Department of Medical Oncology, Glasgow University, U.K.
Kerr
D J
DJ
Setanoians
A
A
Zaharko
D S
DS
Kaye
S B
SB
D000818:Animals; D000970:Antineoplastic Agents / Q000097:blood*; D001798:Blood Proteins / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D005419:Flavonoids / Q000097:blood* / Q000627:therapeutic use; D006801:Humans; D007700:Kinetics; D008433:Mathematics; D051379:Mice; D008962:Models, Theoretical; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy; D011379:Prognosis; D011485:Protein Binding; D013045:Species Specificity
D000970:Antineoplastic Agents; D001798:Blood Proteins; D005419:Flavonoids; C049328:flavone acetic acid